Skip to content

Connecting Money with MedTech

2024’s leading MedTech startup & investor summit

MedTech World

2024

We are a global event management company that hosts an annual investor and entrepreneur conference in the medtech and health tech space in Malta, Europe, alongside multiple premier roadshow events worldwide. At MedTech World, we trust in fostering collaboration among all stakeholders to attain improved healthcare for everyone. At the heart of our mission is a strong belief that each innovative startup deserves funding, and by fostering entrepreneurship, we are contributing to a robust and sustainable healthcare environment. Join over 3,000 attendees from diverse regions including the UK, Europe, North America, Asia, the Middle East, and North Africa. Engage in unparalleled networking meetups, explore investment opportunities with top MedTech investors, and connect with startups at the forefront of transforming the medtech sector.

MedTech World Malta

2,000+

attendees

300+

speakers

200+

partners

300+

startups

100+

investors

Top Speakers

2024 event

Kwame Ulmer

Venture Partner at Wavemaker Three-Sixty Health

Kwame Ulmer is a venture partner at Wavemaker Three-Sixty Health. He leads the medtech practice and participates in all aspects of fund management (e.g. deal sourcing, diligence, negotiation, and advising portfolio company management teams)

Sanchita Pasi

Senior Investment Manager at Sagana

Sanchita Pasi is a Senior Investment Manager at Sagana with a Pharm.D and an MBA from SDA Bocconi. Sanchita’s experience spans across international MedTech product management and commercialization from her time at Abbott Laboratories. She then transitioned to venture capital starting at Nina Capital and now impact investing at Sagana. She is excited to meet founders who are need-driven and fueled by the goal to improve access and affordability for healthcare worldwide. She has indian roots, a mediterranean upbringing, and is also a painter by night.

Joshua Philips

Managing Partner at Catalyst Health Ventures

Thom Rasche

Partner at Earlybird Venture Capital

Thom Rasche is a Partner at the Health Fund of Earlybird Venture Capital, which invests in early-stage companies across digital health, medical devices, diagnostics, R&D platform technologies, and biopharma.
Thom is an experienced healthcare executive with both operational and financial expertise, currently serving on the boards of Alesi Surgical, Polares Medical, and Shape Memory Medical. Prior to joining Earlybird in 2013, he was managing director of Ethicon and VP Europe of Johnson & Johnson. Thom holds a Kaufmann Diploma from the University of Lüneburg.

Catello Somma

Partner at Seroba

Catello Somma is a Partner at Seroba. He has a background in venture capital and clinical development, with a focus on the biotechnology and medical device industries. Catello graduated in 2007 summa cum laude from the University of Naples Federico II and in 2014 completed an MBA at POLIMI Graduate School of Management.

Gautam Kainth

Partner at TCP Health Ventures

Gautam is a Partner at TCP Health Ventures (part of The Capital Partnership Group with AUM of US$ 7 billion) and focuses on early stage investments in medtech space. Gautam serves as a member of Board of Directors for Tioga Cardiovascular Inc., Adona Medical Inc., Plexaa Limited, and Akura Medical Inc. Gautam has over 20+ years of experience in private investments space across various geographies (US, Europe, Asia, and Africa) with total deployed capital of $1+ billion.

Swarna Balasubramaniam

Founder and CEO at Noleus Technologies

Dr. Swarna Balasubramaniam is a surgeon, inventor and medical device entrepreneur. She is the founder of Noleus Technologies, medical device company focused on developing and commercializing innovative technologies intended to accelerate recovery and to improve outcomes after surgery. The first product aims to establish a new standard of care for post-operative ileus through its’ differentiated and proprietary technology to reliably accelerate the return of bowel function after abdominal surgery. She is a board certified surgeon and has 20 years of experience as a practicing surgeon . She was raised in the Boston MA, and completed medical school and general surgery training at the Mayo Clinic in Rochester MN. She worked as a general surgeon at Kaiser Permanente for two years prior to completing a colon & rectal surgery fellowship at The University of Southern California in Los Angeles. She has experience in basic science research in the areas of radiologic imaging, cardio-renal physiology, molecular oncology and in clinical translational surgical research.

Daniel Estay

Founder & CEO at SonoVascular

Daniel is the Founder & CEO of SonoVascular. He has over 35 years of global healthcare experience with a successful track record of building and growing medical technology businesses. Daniel has held senior leadership positions in general management and business development with leading healthcare companies, including Abbott and J&J. He received his BS in Business Administration from Syracuse University and his MBA from the University of Miami.

Spencer Todd

CEO and Co-Founder at FormlyAI

Dr. Spencer Todd has spent his years at FDA, large medical device manufacturers, and as a consultant bringing medical devices to market in the US and the European Union. Spencer founded FormlyAI to create innovative software that provides a fast and affordable option for medical device certification that founders need.

Gary Gershony

Founding General Partner at BayMed Venture Partners

Dr. Gershony is an internationally recognized interventional cardiologist and serial MedTech entrepreneur. He was the Founder of Vascular Solutions, helped lead a successful IPO in 2000, and served as the company’s Chief Medical Officer and Board member. He subsequently co-founded AngioScore which developed novel angioplasty scoring balloons and served as Chief Medical Office and Board member until its acquisition in 2014. Dr. Gershony is a Founding General Partner at BayMed Venture Partners which is based in San Francisco. He currently serves on the boards of multiple medical device companies and is a frequent speaker at investor conferences

Dr. Khulood Alsayegh

Head of Clinical Standards at Health Regulation Sector, Guidelines at Dubai Health Authority

Dr. Khulood Alsayegh, MD, is an accomplished healthcare leader and regulatory advisor, Head of Clinical Standards and Guidelines with Dubai Health Authority, a non- resident fellow researcher with Mohamed Bin Rashid School of Governance and consultant Family Physician. Qualified at the Royal College of Surgeons in Ireland and Harvard Medical school, Boston. She has 20 years of clinical experience in the United States, Europe, the GCC and the United Arab Emirates. Pioneer in Telehealth and AI ethics, certified as the first ethical Lead Assessor in healthcare within the Middle East and Africa, by IEEE. Participated as a speaker in multiple local and international conferences. Won multiple international awards and is currently leading the ongoing development of clinical standards for application to both private and public sectors across the emirate of Dubai.

Assaf Barnea

Managing Partner at Sanara Capital and Sanara Ventures & Chairman at Israel Export Institute – Life Science Board.

Assaf is a seasoned entrepreneur and venture professional with extensive experience in venture investments, building innovation platforms and commercializing and scaling healthcare related startups.
He has been leading Sanara Ventures, an Israel based HealthTech innovation fund backed by Phillips, Teva and the Israel Innovation Authority, since its inception in 2015.

Alex Condon

COO at Galen Data

Alex Condon is a co-founder of Galen Data, a medical device cloud data platform. Previously, Alex was the Chief Strategy officer at Tietronix Software, a NASA contractor focusing on Life Sciences innovations. Alex has represented Healthcare and Space technologies on six Mayor-led international trade missions for the City of Houston.

Youssef Biadillah

Co-founder at Anchor Orthopedics, CEO at BariaTek Medical and CEO at Holistick Medical.

A medical device executive with 20 years of experience developing high impact innovative medical devices and an author of 90+ US patents and patent applications.An early employee of Baylis Medical (acquired by Boston Scientific), Sadra Medical (acquired by Boston Scientific), Symetis (acquired by Boston Scientific) and co-founder of AboGen (acquired by Orasure Technologies). Co-founder of Anchor Orthopedics, a commercial stage medical device company, CEO of BariaTek, an obesity company, and CEO of Holistick Medical, a structural heart company.

Pablo Prieto

Managing Director at CG Health Ventures

Pablo is a former pharma executive and entrepreneur turned investor with CG Health Ventures, investing in early stage medtech and healthtech globally. Its portfolio spans from diagnostics to medical devices and software, and includes over 17 active investments with a strong focus in the USA.

Dave Marver

CEO at ONWARD Medical

Dave Marver serves as CEO of ONWARD Medical, a highly innovative medical technology company developing therapies for people with spinal cord injury. ONWARD has 10 FDA Breakthrough Device Designation Awards and over 240 issued patents covering its neuromodulation and brain-computer interface platforms.

Steven Levy

Partner at Unorthodox Ventures

Steven is a founding member of Unorthodox Ventures. At UV, Steven is involved in all aspects of the investing activities, from deal sourcing and execution to post investment management. Steven represents UV on the boards of Safkan, Tushy, Lumen, Vibrant and Third Pole. Before joining Unorthodox Ventures, Steven worked for the prior 23 years as an investment banker, having held senior roles at Lehman Brothers, Stifel Financial and Cowen & Co. Steven has executed over 100 transactions with aggregate deal value in excess of $30 billion. Steven headed the M&A efforts for the Financial Sponsors practice at Lehman Brothers, covered Financial sponsors and headed the Consumer M&A efforts at Cowen and covered Financial Sponsors, led execution on technology and consumer M&A transactions and headed up the firm’s investment banking efforts in Israel at Stifel. Steven received his B.A. from Binghamton University and graduated as a member of Phi Beta Kappa and received his M.B.A. from the Wharton School, at the University of Pennsylvania.
Steven resides in Lifo Beach, NY.

Mark Lehmkuhle

CEO and founder at Epitel

Mark Lehmkuhle is CEO and founder of Epitel. With a background in Biomedical Engineering, Mark holds a doctorate in Neural Engineering specializing in electrophysiology signal processing. Mark left a career in academia to build Epitel’s wireless, wearable EEG sensors specifically to address the need for improved EEG equity and accessibility.

Albert Huang

Chief Medical Advisor at Northgate Technologies Inc. & Medtech Executive at Lifeblood Capital

Dr. Albert Huang is a surgeon, founder and CEO of Allotrope Medical which was acquired in 2023. With a lifelong passion for solving problems, creative design, and entrepreneurship, he has found success both in the academic setting as well as within medtech innovation.

Darcy Bachert

CEO at Prolucid Technologies

Darcy Bachert is the Founder and CEO of Prolucid, an ISO 13485 certified software engineering firm that specializes in custom medical software development. Over the past 16 years Darcy has grown Prolucid to a team of 25, supporting innovative medtech companies across the world in successfully bringing their applications and devices to market.

John Perez

Managing Director at Rex Heath Ventures

John is an accomplished healthcare leader with over a decade of experience collaborating with health systems, healthcare partners, and early-stage companies. His expertise spans strategic venture capital investments, innovation, advisory services, and financial consulting. Currently, as a Managing Director at Rex Health Ventures (RHV), he co-leads the corporate venture arm of UNC Health, driving a culture of innovation and delivering financial returns through strategic equity investments in early-stage companies.

Our Partners

We proudly collaborate with over 200 partners in the MedTech space, including top medical device venture capitalists, industry leaders, and tech innovators. Join us in driving healthcare innovation and investment in the global MedTech landscape.
5
Key Partners
150+
Supporters
100+
Investors
150+
Startups
50+
Media Partners

Interested in sponsoring MedTech World’s next event?

Let’s Connect

Startup Pitch

A unique opportunity for entrepreneurs to gain exposure, receive feedback, and secure funding for their ventures
What’s included?

booth

presentation

consultancy

networking

PR

leads

apply now

Moments from our events

Testimonials

What others have to say after experiencing MedTech Malta 2023

Kwame Ulmer

Venture Partner, Wavemaker Three-Sixty Health

Med-Tech World is special. It is the only event that has featured a head of state, investors from around the world focused on medtech and serious entrepreneurs. The conveners have produced a delightful and immersive experience in a setting that invites expansive conversations. I believe this formula will drive the success of medtech companies and move their solutions towards expanded patient access.

Martin Gomez

Partner & Co-Head MedTech Practice, Group Goodwin Procter

MedTech Malta was the best conference I have been to in a long time. Not only did it offer plentiful networking opportunities with high caliber Medtech companies and investors, but the panel discussions were both relevant and engaging. The event did not disappoint and I look forward to returning again next year.

Julie Adrian

Founder & CEO, Alverium Health

“Med-Tech World 2023 was one of the best tradeshow experiences I’ve ever had. It provided an excellent platform to share the Alverium Health story, as it was intimate enough to meet almost everyone there and interact with them in a meaningful way. With a solid mix of both innovators and investors in attendance, everybody was very accessible and we were able to make some outstanding connections that have already provided value to both our clients and the growth of our business. We are already looking forward to what MTW 2024 has to offer!

Linus Rieder

Principal, 415 Capital Management GmbH

A very intimate conference that provides a great mix of startups and investors, not to forget to mention that it takes place on a stunning Island!

Amir Soltanianzadeh

Founder & Managing Partner, Solardis Health Ventures

MedTech Malta brings together the leading MedTech entrepreneurs, investors, and strategics at one of the most unique venues in the world. This is a must-attend event for you everyone in MedTech, and I will be there every year.

lloyd Diamond

CEO, Pixium Vision

The Medtech Malta conference was a well-organized event that provided an excellent forum to interact with many of the thought leaders in the global medtech industry. As the CEO of a disruptive medtech company, it can be quite lonely at times. It was great to spend time with other CEOs in similar situations and get re-energized

Pierre Attard

Managing Director, PTL Limited

Our presence at the Med-Tech World Conference aided us in increasing our exposure in the digital health industry. Being awarded ‘Best Contributor to Local Healthcare Industry’ at the Med-Tech World Awards Gala topped it off. We eagerly look forward to their continued contributions at future Med-Tech World events.”

Maria Bugeja

CEO, JamesCo

The Med-Tech World Summit was an incredible experience for us at Jamesco. This event beautifully brings together the medical industry’s key stakeholders showcasing their innovation trends, technologies, and products and the potential stakeholders interested in such products. Jamesco took this opportunity to host a doctors’ educational lunch during the event and proudly introduced two new exciting products for Malta and Europe. The participating audience could not have been better selected for our purpose.

Oliver Bisazza

CEO, MedTech Europe

Innovation in the medical technology industry is the lifeblood of progress in healthcare. It drives the development of cutting-edge medical devices and technologies that save lives, enhance patient care, and improve healthcare delivery. Embracing and nurturing innovation is not just a choice; it’s an imperative for ensurin a brighter and healthier future for all.

Dr. Sanjay Shrivastava

CEO, Innova Vascular, Inc.

Med-Tech World is the best investor conference that I have ever attended. It offered a friendly environment for startup companies to mingle with potential investors. The investors were consistently present at the event and were generally approachable. I enjoyed the interactions with fellow CEOs. I also found the panel discussions to be informative. Lastly, it was nice to have the prime minister of Malta attend the event to deliver a keynote speech. I’d go back to this event again.

Expand Your Network with MedTech Match

MedTech Match is designed to facilitate meaningful connections and set up one-on-one meetings among attendees before, during, and after our events. It’s your gateway to engage with industry leaders, innovators, and investors, enhancing your networking experience in the MedTech community.